My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 773

    1.

    Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance.

    Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, Vatrano M, Succurro E, Lauro R, Federici M, Perticone F.

    Diabetes Care. 2005 Jan;28(1):120-5.PMID: 15616244 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

    Meis SB, Schuster D, Gaillard T, Osei K.

    Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles

    3.

    C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups.

    Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K.

    Atherosclerosis. 2003 Sep;170(1):79-86.PMID: 12957685 [PubMed - indexed for MEDLINE]Related articles

    4.

    Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians.

    Cardellini M, Andreozzi F, Laratta E, Marini MA, Lauro R, Hribal ML, Perticone F, Sesti G.

    Diabetes Metab Res Rev. 2007 Feb;23(2):141-5.PMID: 16952201 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.

    Gonzélez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Pérez BA.

    Diabetes Care. 1994 May;17(5):397-404.PMID: 8062606 [PubMed - indexed for MEDLINE]Related articles

    6.

    Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients.

    Maccario M, Ramunni J, Oleandri SE, Procopio M, Grottoli S, Rossetto R, Savio P, Aimaretti G, Camanni F, Ghigo E.

    Int J Obes Relat Metab Disord. 1999 Jun;23(6):612-8.PMID: 10411234 [PubMed - indexed for MEDLINE]Related articles

    7.

    A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.

    Nauck MA, Meier JJ, Wolfersdorff AV, Tillil H, Creutzfeldt W, Köbberling J.

    Acta Diabetol. 2003 Dec;40(4):163-72.PMID: 14740275 [PubMed - indexed for MEDLINE]Related articles

    8.

    Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.

    Gannagé-Yared MH, Fares F, Semaan M, Khalife S, Jambart S.

    Clin Endocrinol (Oxf). 2006 Jun;64(6):652-8.PMID: 16712667 [PubMed - indexed for MEDLINE]Related articles

    9.

    Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.

    Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.

    Clin Endocrinol (Oxf). 2004 Jul;61(1):75-80.PMID: 15212647 [PubMed - indexed for MEDLINE]Related articles

    10.

    Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

    Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V.

    Metabolism. 2005 Apr;54(4):476-81.PMID: 15798954 [PubMed - indexed for MEDLINE]Related articles

    11.

    Serum ferritin as a component of the insulin resistance syndrome.

    Fernández-Real JM, Ricart-Engel W, Arroyo E, Balançá R, Casamitjana-Abella R, Cabrero D, Fernández-Castañer M, Soler J.

    Diabetes Care. 1998 Jan;21(1):62-8.PMID: 9580307 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity.

    Fernández-Real JM, Broch M, Richart C, Vendrell J, López-Bermejo A, Ricart W.

    J Clin Endocrinol Metab. 2003 Apr;88(4):1780-4.PMID: 12679473 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.

    Salomaa VV, Tuomilehto J, Jauhiainen M, Korhonen HJ, Stengård J, Uusitupa M, Pitkanen M, Penttila I.

    Diabetes Care. 1992 May;15(5):657-65.PMID: 1516486 [PubMed - indexed for MEDLINE]Related articles

    14.

    Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

    Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A, Gibson JM.

    Diabetologia. 2001 Mar;44(3):333-9.PMID: 11317665 [PubMed - indexed for MEDLINE]Related articles

    15.

    Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.

    Yang G, Li L, Chen W, Liu H, Boden G, Li K.

    Ann Med. 2009;41(1):52-6.PMID: 18618352 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hyperleptinaemia: the missing link in the, metabolic syndrome?

    de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G, Alberti KG.

    Diabet Med. 1997 Mar;14(3):200-8.PMID: 9088768 [PubMed - indexed for MEDLINE]Related articles

    17.

    Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.

    Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, Young RJ, White A, Gibson JM.

    Diabetes. 2002 Aug;51(8):2629-36.PMID: 12145180 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

    Osei K, Gaillard T, Schuster D.

    Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.

    Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G.

    Obes Res. 2002 Aug;10(8):717-25.PMID: 12181379 [PubMed - indexed for MEDLINE]Related articles

    20.

    Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Diabetes Care. 2004 Jun;27(6):1439-46.PMID: 15161801 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity